The research progress of lipoxin and metabolic diseases
Author:
Affiliation:

1.Department of Clinical Laboratory, the Gaoping District People's Hospital of Nanchong, Nanchong, Sichuan 637100, China;2.Research Center for Transformation of Medical Studies, North Sichuan Medical College, Nanchong, Sichuan 637000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Lipoxins (LX), metabolites of arachidonic acid, are one of the most important endogenous lipid mediators which initiate inhibition in ammatory reaction as well as promote extinction of in ammation resolution. Nowadays, the role of LX in diabetes, obesity, cardiovascular disease and other metabolic diseases has attracted wide attention. Therefore, this paper reviews the biological function of LX and its research progress in metabolic diseases.

    Reference
    Related
    Cited by
Get Citation

WANG Lizhu, LONG Fan, ZHONG Xiaowu, LI Jiulong. The research progress of lipoxin and metabolic diseases[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(8):733-736.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 03,2019
  • Revised:October 27,2019
  • Online: July 03,2020
Article QR Code